Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotake Sakuraba

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Men'S Health|August 29, 2022
Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver DiseaseChikara Iino, Tetsu Endo, Kaori Iino, et al.
In Vivo (Athens, Greece)|June 23, 2022
Tacrolimus Up-regulates Expression of TGFβ Receptor Type II <i>via</i> ERK, Providing Protection Against Intestinal Epithelial InjuryMiwa Satake, Hirotake Sakuraba, Hiroto Hiraga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 2, 2007
[Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer]Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
International Cancer Conference Journal|March 31, 2025
Coexistence of plasmablastic lymphoma and adenocarcinoma in the stomach: a case report and literature reviewTakato Maeda, Takenori Takahata, Shintaro Goto, et al.
Journal of Clinical Biochemistry and Nutrition|September 18, 2025
Influence of transarterial chemoembolization on serum opsonic activity in hepatocellular carcinoma measured by chemiluminescenceSatoshi Sato, Daisuke Chinda, Misa Ozaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 23, 2024
An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction-associated steatotic liver disease among the general populationSatoshi Sato, Chikara Iino, Takafumi Sasada, et al.
Nutrients|September 14, 2024
The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver FibrosisTakafumi Sasada, Chikara Iino, Satoshi Sato, et al.
Molecular Immunology|December 1, 2020
Tryptanthrin suppresses double-stranded RNA-induced CXCL10 expression via inhibiting the phosphorylation of STAT1 in human umbilical vein endothelial cellsShogo Kawaguchi, Hirotake Sakuraba, Hidezumi Kikuchi, et al.
Genes|September 28, 2024
Epidemiological Study on the Interaction between the <i>PNPLA3</i> (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSatoshi Sato, Chikara Iino, Takafumi Sasada, et al.
DEN Open|September 4, 2023
Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case reportShohei Igarashi, Norihiro Hanabata, Keisuke Furusawa, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Men'S Health|August 29, 2022
Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver DiseaseChikara Iino, Tetsu Endo, Kaori Iino, et al.
In Vivo (Athens, Greece)|June 23, 2022
Tacrolimus Up-regulates Expression of TGFβ Receptor Type II <i>via</i> ERK, Providing Protection Against Intestinal Epithelial InjuryMiwa Satake, Hirotake Sakuraba, Hiroto Hiraga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 2, 2007
[Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer]Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
International Cancer Conference Journal|March 31, 2025
Coexistence of plasmablastic lymphoma and adenocarcinoma in the stomach: a case report and literature reviewTakato Maeda, Takenori Takahata, Shintaro Goto, et al.
Journal of Clinical Biochemistry and Nutrition|September 18, 2025
Influence of transarterial chemoembolization on serum opsonic activity in hepatocellular carcinoma measured by chemiluminescenceSatoshi Sato, Daisuke Chinda, Misa Ozaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 23, 2024
An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction-associated steatotic liver disease among the general populationSatoshi Sato, Chikara Iino, Takafumi Sasada, et al.
Nutrients|September 14, 2024
The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver FibrosisTakafumi Sasada, Chikara Iino, Satoshi Sato, et al.
Molecular Immunology|December 1, 2020
Tryptanthrin suppresses double-stranded RNA-induced CXCL10 expression via inhibiting the phosphorylation of STAT1 in human umbilical vein endothelial cellsShogo Kawaguchi, Hirotake Sakuraba, Hidezumi Kikuchi, et al.
Genes|September 28, 2024
Epidemiological Study on the Interaction between the <i>PNPLA3</i> (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSatoshi Sato, Chikara Iino, Takafumi Sasada, et al.
DEN Open|September 4, 2023
Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case reportShohei Igarashi, Norihiro Hanabata, Keisuke Furusawa, et al.
Pageof 12